Related Experiment Video

Updated: Sep 23, 2026

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

Medical importance of biofilms in Candida infections

L Julia Douglas1

  • 1Division of Infection and Immunity, Institute of Biomedical and Life Sciences, Joseph Black Building, University of Glasgow, Glasgow, G12 8QQ, UK. J.Douglas@bio.gla.ac.uk

Revista Iberoamericana De Micologia
|June 27, 2003
PubMed

Insights

Candida biofilms form on medical devices and resist antifungal drugs. Research is exploring the multiple mechanisms behind this drug resistance in Candida biofilms.

Area of Science:

  • Medical Mycology
  • Biomaterials Science
  • Infectious Diseases

Background:

  • Candida infections frequently involve biofilm formation on implanted medical devices.
  • Biofilms pose a significant challenge in clinical settings, particularly on devices like catheters, prosthetic heart valves, and dentures.

Purpose of the Study:

  • To investigate the structural characteristics of Candida biofilms formed in vitro.
  • To understand the inherent resistance of Candida biofilms to common antifungal agents.

Main Methods:

  • In vitro biofilm formation using simple model systems on catheter material and denture acrylic discs.
  • Microscopic analysis of biofilm structure, including yeasts, hyphae, and pseudohyphae arrangement.
  • Assessment of biofilm resistance to clinically used antifungal agents.

Main Results:

  • Candida biofilms exhibit a distinct bilayer structure composed of matrix-enclosed microcolonies.
  • These biofilms demonstrate significant resistance to established antifungal drugs such as amphotericin B and fluconazole.
  • Multiple underlying mechanisms contribute to the observed drug resistance in Candida biofilms.

Conclusions:

  • Candida biofilms on medical devices present a complex, drug-resistant challenge.
  • Understanding the structural and mechanistic basis of biofilm resistance is crucial for developing effective treatment strategies.
  • Further research into biofilm drug resistance mechanisms is warranted.

More Related Videos

Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging08:31

Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging

Published on: January 27, 2015

Clarifying and Imaging Candida albicans Biofilms11:09

Clarifying and Imaging Candida albicans Biofilms

Published on: March 6, 2020

Related Concept Videos

Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...